| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.2 | 6e-06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |